VCJ Staff

Dicerna Pharma Raises $25 Million

Dicerna Pharmaceuticals Inc., a Cambridge, Mass.-based RNA interference company, has raised $25 million in Series B funding. Domain Associates led the round, and was joined by return backers Oxford Bioscience Partners, Abingworth Management and Skyline Ventures. The company previously raised $21.4 million.

TetraLogic Pharma Raises $32 Million

TetraLogic Pharmaceuticals, a Malvern, Penn.-based developer of small molecule drugs to treat cancer, has raised $32 million in Series C funding. Clarus Ventures led the round, and was joined by Hatteras Venture Partners and return backers Amgen Ventures, HealthCare Ventures, Latterell Venture Partners, Novitas Capital, Quaker BioVentures and the Vertical Group.

Ciespace Raises $4 Million

Ciespace Corp., a Pittsbuirgh-based developer of a 3D digital modeling platform, has raised $4 million in Series A funding co-led by Arch Venture Partners and The University of Tokyo-Edge Capital.

OptiMedica Selling Retina and Glaucoma Assets

OptiMedica Inc., a Santa Clara, Calif.-based ophthalmic device company, has agreed to sell its retina and glaucoma assets to Topcon Corp. No financial terms were disclosed. OptiMedica has raised nearly $52 million in VC funding from DAG Ventures, Kleiner Perkins Caufield & Byers and Alloy Ventures.

China Kanghui Prices IPO

MediaMind Prices Low IPO

Canadian VC Market Shows Signs of Revovery

G5 Raises $15 Million

G5, a Bend, Ore.-based provider of vertical-specific local marketing solutions, has raised $15 million in first-round funding led by Volition Capital.

Medialets Raises $6 Million

Medialets, a New York-based ad technology platform for mobile applications, has raised $6 million in Series B funding. Existing backer Foundry Group led the round, and was joined by DFJ Gotham, 500 Startups and Chris Saridakis. The company previously raised $4 million.

CRE Secure Raises $3.18 Million

CRE Secure, an Atlanta-based payment solution for online merchants, has raised $3.18 million in funding from Total Technology Ventures, Miller Capital Partners and individual angels.